SC 13D Filing

Company

LIGAND PHARMACEUTICALS INC

Filed

September 13, 1994

Accession Number

0000005187-94-000018

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →